ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hypertension and Heart Failure Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-36Z7273
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Hypertension and Heart Failure Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Hypertension and Heart Failure Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-36Z7273
Report
December 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Menarini Group
Johnson & Johnson
Lupin Ltd
Boehringer Ingelheim
Novartis
Merck
Astrazeneca plc
Pfizer Inc
Sanofi SA
Dr. Reddy’s Laboratories
Daiichi Sankyo Company Limited

Hypertension and Heart Failure Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hypertension and Heart Failure Drugs Market

Hypertension and Heart Failure Drugs Market

Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.
Market Analysis and Insights: Global Hypertension and Heart Failure Drugs Market
The global Hypertension and Heart Failure Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Hypertension and Heart Failure Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hypertension and Heart Failure Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hypertension and Heart Failure Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hypertension and Heart Failure Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hypertension and Heart Failure Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hypertension and Heart Failure Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Hypertension and Heart Failure Drugs Market Report

Report Metric Details
Report Name Hypertension and Heart Failure Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Men
  • Women
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Menarini Group, Johnson & Johnson, Lupin, Boehringer Ingelheim, Novartis, Merck & Co, AstraZeneca, Pfizer, Inc, Sanofi SA, Dr. Reddy's Laboratories, Daiichi Sankyo Company Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Hypertension and Heart Failure Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hypertension and Heart Failure Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hypertension and Heart Failure Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Hypertension and Heart Failure Drugs Market report?

Ans: The main players in the Hypertension and Heart Failure Drugs Market are Menarini Group, Johnson & Johnson, Lupin, Boehringer Ingelheim, Novartis, Merck & Co, AstraZeneca, Pfizer, Inc, Sanofi SA, Dr. Reddy's Laboratories, Daiichi Sankyo Company Limited

What are the Application segmentation covered in the Hypertension and Heart Failure Drugs Market report?

Ans: The Applications covered in the Hypertension and Heart Failure Drugs Market report are Men, Women

What are the Type segmentation covered in the Hypertension and Heart Failure Drugs Market report?

Ans: The Types covered in the Hypertension and Heart Failure Drugs Market report are Diuretics, Beta Blockers, Ace Inhibitors, Alpha Blockers, Others

Recommended Reports

Cardiovascular Therapeutics

Heart Failure & Ischemia

Hypertension & Diuretics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diuretics
1.2.3 Beta Blockers
1.2.4 Ace Inhibitors
1.2.5 Alpha Blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Men
1.3.3 Women
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension and Heart Failure Drugs Market Perspective (2019-2030)
2.2 Global Hypertension and Heart Failure Drugs Growth Trends by Region
2.2.1 Hypertension and Heart Failure Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hypertension and Heart Failure Drugs Historic Market Size by Region (2019-2024)
2.2.3 Hypertension and Heart Failure Drugs Forecasted Market Size by Region (2025-2030)
2.3 Hypertension and Heart Failure Drugs Market Dynamics
2.3.1 Hypertension and Heart Failure Drugs Industry Trends
2.3.2 Hypertension and Heart Failure Drugs Market Drivers
2.3.3 Hypertension and Heart Failure Drugs Market Challenges
2.3.4 Hypertension and Heart Failure Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hypertension and Heart Failure Drugs by Players
3.1.1 Global Hypertension and Heart Failure Drugs Revenue by Players (2019-2024)
3.1.2 Global Hypertension and Heart Failure Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Hypertension and Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hypertension and Heart Failure Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hypertension and Heart Failure Drugs Market Concentration Ratio
3.4.1 Global Hypertension and Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension and Heart Failure Drugs Revenue in 2023
3.5 Global Key Players of Hypertension and Heart Failure Drugs Head office and Area Served
3.6 Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
3.7 Global Key Players of Hypertension and Heart Failure Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension and Heart Failure Drugs Breakdown Data by Type
4.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Type (2019-2024)
4.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2025-2030)
5 Hypertension and Heart Failure Drugs Breakdown Data by Application
5.1 Global Hypertension and Heart Failure Drugs Historic Market Size by Application (2019-2024)
5.2 Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hypertension and Heart Failure Drugs Market Size (2019-2030)
6.2 North America Hypertension and Heart Failure Drugs Market Size by Type
6.2.1 North America Hypertension and Heart Failure Drugs Market Size by Type (2019-2024)
6.2.2 North America Hypertension and Heart Failure Drugs Market Size by Type (2025-2030)
6.2.3 North America Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
6.3 North America Hypertension and Heart Failure Drugs Market Size by Application
6.3.1 North America Hypertension and Heart Failure Drugs Market Size by Application (2019-2024)
6.3.2 North America Hypertension and Heart Failure Drugs Market Size by Application (2025-2030)
6.3.3 North America Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
6.4 North America Hypertension and Heart Failure Drugs Market Size by Country
6.4.1 North America Hypertension and Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hypertension and Heart Failure Drugs Market Size by Country (2019-2024)
6.4.3 North America Hypertension and Heart Failure Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hypertension and Heart Failure Drugs Market Size (2019-2030)
7.2 Europe Hypertension and Heart Failure Drugs Market Size by Type
7.2.1 Europe Hypertension and Heart Failure Drugs Market Size by Type (2019-2024)
7.2.2 Europe Hypertension and Heart Failure Drugs Market Size by Type (2025-2030)
7.2.3 Europe Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
7.3 Europe Hypertension and Heart Failure Drugs Market Size by Application
7.3.1 Europe Hypertension and Heart Failure Drugs Market Size by Application (2019-2024)
7.3.2 Europe Hypertension and Heart Failure Drugs Market Size by Application (2025-2030)
7.3.3 Europe Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
7.4 Europe Hypertension and Heart Failure Drugs Market Size by Country
7.4.1 Europe Hypertension and Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hypertension and Heart Failure Drugs Market Size by Country (2019-2024)
7.4.3 Europe Hypertension and Heart Failure Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hypertension and Heart Failure Drugs Market Size (2019-2030)
8.2 China Hypertension and Heart Failure Drugs Market Size by Type
8.2.1 China Hypertension and Heart Failure Drugs Market Size by Type (2019-2024)
8.2.2 China Hypertension and Heart Failure Drugs Market Size by Type (2025-2030)
8.2.3 China Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
8.3 China Hypertension and Heart Failure Drugs Market Size by Application
8.3.1 China Hypertension and Heart Failure Drugs Market Size by Application (2019-2024)
8.3.2 China Hypertension and Heart Failure Drugs Market Size by Application (2025-2030)
8.3.3 China Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hypertension and Heart Failure Drugs Market Size (2019-2030)
9.2 Asia Hypertension and Heart Failure Drugs Market Size by Type
9.2.1 Asia Hypertension and Heart Failure Drugs Market Size by Type (2019-2024)
9.2.2 Asia Hypertension and Heart Failure Drugs Market Size by Type (2025-2030)
9.2.3 Asia Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
9.3 Asia Hypertension and Heart Failure Drugs Market Size by Application
9.3.1 Asia Hypertension and Heart Failure Drugs Market Size by Application (2019-2024)
9.3.2 Asia Hypertension and Heart Failure Drugs Market Size by Application (2025-2030)
9.3.3 Asia Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
9.4 Asia Hypertension and Heart Failure Drugs Market Size by Region
9.4.1 Asia Hypertension and Heart Failure Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hypertension and Heart Failure Drugs Market Size by Region (2019-2024)
9.4.3 Asia Hypertension and Heart Failure Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Menarini Group
11.1.1 Menarini Group Company Details
11.1.2 Menarini Group Business Overview
11.1.3 Menarini Group Hypertension and Heart Failure Drugs Introduction
11.1.4 Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.1.5 Menarini Group Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Hypertension and Heart Failure Drugs Introduction
11.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 Lupin
11.3.1 Lupin Company Details
11.3.2 Lupin Business Overview
11.3.3 Lupin Hypertension and Heart Failure Drugs Introduction
11.3.4 Lupin Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.3.5 Lupin Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Hypertension and Heart Failure Drugs Introduction
11.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Hypertension and Heart Failure Drugs Introduction
11.5.4 Novartis Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.5.5 Novartis Recent Developments
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Hypertension and Heart Failure Drugs Introduction
11.6.4 Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.6.5 Merck & Co Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Hypertension and Heart Failure Drugs Introduction
11.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.7.5 AstraZeneca Recent Developments
11.8 Pfizer, Inc
11.8.1 Pfizer, Inc Company Details
11.8.2 Pfizer, Inc Business Overview
11.8.3 Pfizer, Inc Hypertension and Heart Failure Drugs Introduction
11.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.8.5 Pfizer, Inc Recent Developments
11.9 Sanofi SA
11.9.1 Sanofi SA Company Details
11.9.2 Sanofi SA Business Overview
11.9.3 Sanofi SA Hypertension and Heart Failure Drugs Introduction
11.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.9.5 Sanofi SA Recent Developments
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Details
11.10.2 Dr. Reddy's Laboratories Business Overview
11.10.3 Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Introduction
11.10.4 Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.10.5 Dr. Reddy's Laboratories Recent Developments
11.11 Daiichi Sankyo Company Limited
11.11.1 Daiichi Sankyo Company Limited Company Details
11.11.2 Daiichi Sankyo Company Limited Business Overview
11.11.3 Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Introduction
11.11.4 Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2019-2024)
11.11.5 Daiichi Sankyo Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Menarini Group
Johnson & Johnson
Lupin Ltd
Boehringer Ingelheim
Novartis
Merck
Astrazeneca plc
Pfizer Inc
Sanofi SA
Dr. Reddy’s Laboratories
Daiichi Sankyo Company Limited
List of Tables
    Table 1. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Diuretics
    Table 3. Key Players of Beta Blockers
    Table 4. Key Players of Ace Inhibitors
    Table 5. Key Players of Alpha Blockers
    Table 6. Key Players of Others
    Table 7. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Hypertension and Heart Failure Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Hypertension and Heart Failure Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Hypertension and Heart Failure Drugs Market Share by Region (2019-2024)
    Table 11. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Hypertension and Heart Failure Drugs Market Share by Region (2025-2030)
    Table 13. Hypertension and Heart Failure Drugs Market Trends
    Table 14. Hypertension and Heart Failure Drugs Market Drivers
    Table 15. Hypertension and Heart Failure Drugs Market Challenges
    Table 16. Hypertension and Heart Failure Drugs Market Restraints
    Table 17. Global Hypertension and Heart Failure Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Hypertension and Heart Failure Drugs Revenue Share by Players (2019-2024)
    Table 19. Global Top Hypertension and Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2023)
    Table 20. Global Hypertension and Heart Failure Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Hypertension and Heart Failure Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Hypertension and Heart Failure Drugs, Headquarters and Area Served
    Table 23. Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
    Table 24. Global Key Players of Hypertension and Heart Failure Drugs, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2019-2024)
    Table 28. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Hypertension and Heart Failure Drugs Revenue Market Share by Type (2025-2030)
    Table 30. Global Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Hypertension and Heart Failure Drugs Revenue Share by Application (2019-2024)
    Table 32. Global Hypertension and Heart Failure Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Hypertension and Heart Failure Drugs Revenue Share by Application (2025-2030)
    Table 34. North America Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Hypertension and Heart Failure Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Hypertension and Heart Failure Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Hypertension and Heart Failure Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Hypertension and Heart Failure Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Hypertension and Heart Failure Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Hypertension and Heart Failure Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Hypertension and Heart Failure Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Hypertension and Heart Failure Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Hypertension and Heart Failure Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Hypertension and Heart Failure Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Hypertension and Heart Failure Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Hypertension and Heart Failure Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Hypertension and Heart Failure Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Hypertension and Heart Failure Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Menarini Group Company Details
    Table 67. Menarini Group Business Overview
    Table 68. Menarini Group Hypertension and Heart Failure Drugs Product
    Table 69. Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 70. Menarini Group Recent Developments
    Table 71. Johnson & Johnson Company Details
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Hypertension and Heart Failure Drugs Product
    Table 74. Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 75. Johnson & Johnson Recent Developments
    Table 76. Lupin Company Details
    Table 77. Lupin Business Overview
    Table 78. Lupin Hypertension and Heart Failure Drugs Product
    Table 79. Lupin Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 80. Lupin Recent Developments
    Table 81. Boehringer Ingelheim Company Details
    Table 82. Boehringer Ingelheim Business Overview
    Table 83. Boehringer Ingelheim Hypertension and Heart Failure Drugs Product
    Table 84. Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 85. Boehringer Ingelheim Recent Developments
    Table 86. Novartis Company Details
    Table 87. Novartis Business Overview
    Table 88. Novartis Hypertension and Heart Failure Drugs Product
    Table 89. Novartis Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 90. Novartis Recent Developments
    Table 91. Merck & Co Company Details
    Table 92. Merck & Co Business Overview
    Table 93. Merck & Co Hypertension and Heart Failure Drugs Product
    Table 94. Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 95. Merck & Co Recent Developments
    Table 96. AstraZeneca Company Details
    Table 97. AstraZeneca Business Overview
    Table 98. AstraZeneca Hypertension and Heart Failure Drugs Product
    Table 99. AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 100. AstraZeneca Recent Developments
    Table 101. Pfizer, Inc Company Details
    Table 102. Pfizer, Inc Business Overview
    Table 103. Pfizer, Inc Hypertension and Heart Failure Drugs Product
    Table 104. Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 105. Pfizer, Inc Recent Developments
    Table 106. Sanofi SA Company Details
    Table 107. Sanofi SA Business Overview
    Table 108. Sanofi SA Hypertension and Heart Failure Drugs Product
    Table 109. Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 110. Sanofi SA Recent Developments
    Table 111. Dr. Reddy's Laboratories Company Details
    Table 112. Dr. Reddy's Laboratories Business Overview
    Table 113. Dr. Reddy's Laboratories Hypertension and Heart Failure Drugs Product
    Table 114. Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 115. Dr. Reddy's Laboratories Recent Developments
    Table 116. Daiichi Sankyo Company Limited Company Details
    Table 117. Daiichi Sankyo Company Limited Business Overview
    Table 118. Daiichi Sankyo Company Limited Hypertension and Heart Failure Drugs Product
    Table 119. Daiichi Sankyo Company Limited Revenue in Hypertension and Heart Failure Drugs Business (2019-2024) & (US$ Million)
    Table 120. Daiichi Sankyo Company Limited Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Hypertension and Heart Failure Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Diuretics Features
    Figure 4. Beta Blockers Features
    Figure 5. Ace Inhibitors Features
    Figure 6. Alpha Blockers Features
    Figure 7. Others Features
    Figure 8. Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Hypertension and Heart Failure Drugs Market Share by Application: 2023 VS 2030
    Figure 10. Men Case Studies
    Figure 11. Women Case Studies
    Figure 12. Hypertension and Heart Failure Drugs Report Years Considered
    Figure 13. Global Hypertension and Heart Failure Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Hypertension and Heart Failure Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Hypertension and Heart Failure Drugs Market Share by Region: 2023 VS 2030
    Figure 16. Global Hypertension and Heart Failure Drugs Market Share by Players in 2023
    Figure 17. Global Top Hypertension and Heart Failure Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension and Heart Failure Drugs as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Hypertension and Heart Failure Drugs Revenue in 2023
    Figure 19. North America Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
    Figure 21. North America Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
    Figure 22. North America Hypertension and Heart Failure Drugs Market Share by Country (2019-2030)
    Figure 23. United States Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Hypertension and Heart Failure Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
    Figure 27. Europe Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
    Figure 28. Europe Hypertension and Heart Failure Drugs Market Share by Country (2019-2030)
    Figure 29. Germany Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Hypertension and Heart Failure Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
    Figure 37. China Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
    Figure 38. Asia Hypertension and Heart Failure Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
    Figure 40. Asia Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
    Figure 41. Asia Hypertension and Heart Failure Drugs Market Share by Region (2019-2030)
    Figure 42. Japan Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Hypertension and Heart Failure Drugs Market Share by Country (2019-2030)
    Figure 52. Brazil Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Hypertension and Heart Failure Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 60. Lupin Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 63. Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 64. AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 65. Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 66. Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 67. Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 68. Daiichi Sankyo Company Limited Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Hypertension and Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medicines for Congestive Heart Failure Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Heart Failure CHF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hypertension Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Heart Failure Therapeutics Market Research Report 2024
Global Antihypertensive Drugs Market Research Report 2024
Global Heart Failure Treatment Market Insights Forecast to 2030
Global Hypertensive Heart Disease Drug Market Research Report 2025
Hypertension Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Essential Hypertension Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orthostatic Hypotension Drugs Market Insights Forecast to 2030
Global Intraocular Antihypertensive Market Research Report 2025
Blood Pressure Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ramipril API Market Research Report 2025
Global Irbesartan Market Research Report 2024
Treatment Resistant Hypertension Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Congestive Heart Failure Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin II Receptor Blocker ARBs API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enalapril Market Research Report 2024

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions